Form 4 for ABT Abbott Laboratories
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001620564-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABT | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | F - Tax | $116.26 | -6,615 | 147.3K | -4% | -$769.1K | |
| 2026-03-03 | 2026-03-02 | ABT | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | S - Sale | $115.58 | -885 | 146.4K | -0.6% | -$102.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2026-02-27 | F | D | 6,615 | $116.26 | 147,262 | D | — | — | |
| 2 | Common | Common shares without par value | 2026-03-02 | S | D | 885 | $115.58 | 146,377 | D | — | — |